Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings From 2010 to 2019
Carlota F. Prendes,Barbara Rantner,Tarek Hamwi,Jan Stana,Valery L. Feigin,Konstantinos Stavroulakis,Nikolaos Tsilimparis,Carlota Fernandez Prendes,Barbara Rantner,Tarek Hamwi,Jan Stana,Prof Valery L Feigin,Konstantinos Stavroulakis,Nikolaos Tsilimparis,Prof Victor Aboyans,Rufus Olusola Akinyemi,Prof Rustam Al-Shahi Salman,Anton A Artamonov,Avinash Aujayeb,Marzia Baldereschi,Sanjay Basu,Prof Yannick Béjot,Luis Belo,Derrick A Bennett,Akshaya Srikanth Bhagavathula,Boris Bikbov,Prof Hermann Brenner,Florentino Luciano Caetano dos Santos,Prof Juan J Carrero,Prof Felix Carvalho,Prof Alberico L Catapano,Periklis Charalampous,Prof Hanne Christensen,Sheng-Chia Chung,Paolo Angelo Cortesi,Vera Marisa Costa,Malgorzata Cyganska,Emanuele D’Amico,Kairat Davletov,Klara Georgieva Dokova,Abdel Douiri,Adeniyi Francis Fagbamigbe,Florian Fischer,Nermin Ghith,Simona Giampaoli,Prof Paramjit Singh Gill,Elena V Gnedovskaya,Rasmus J Havmoeller,Sorin Hostiuc,Prof Ivo Iavicoli,Prof Milena D Ilic,Prof Gaetano Isola,Jacek Jerzy Jozwiak,Mikk Jürisson,Gbenga A Kayode,Moien AB Khan,Prof Khaled Khatab,Prof Adnan Kisa,Prof Mika Kivimäki,Ai Koyanagi,Mukhtar Kulimbet,Dian Kusuma,Prof Carlo La Vecchia,Ben Lacey,Prof Tea Lallukka,Prof Stefan Lorkowski,Prof Azeem Majeed,Prof Lorenzo Giovanni Mantovani,Giampiero Mazzaglia,Alexios-Fotios A Mentis,Atte Meretoja,Junmei Miao Jonasson,Andreea Mirica,Prof Erkin M Mirrakhimov,Shafiu Mohammed,Mariam Molokhia,Lorenzo Monasta,Prof Ute Mons,Jakub Morze,Ruxandra Irina Negoi,Prof Bo Norrving,Prof Bogdan Oancea,Rónán O’Caoimh,Hans Orru,Alicia Padron-Monedero,Paolo Pedersini,Norberto Perico,Roman V Polibin,Suzanne Polinder,Alberto Raggi,Prof Salman Rawaf,Prof Giuseppe Remuzzi,Michele Romoli,Prof Simona Sacco,Prof Mohammad Reza Saeb,João Vasco Santos,Prof Milena M Santric-Milicevic,Anna Aleksandrovna Skryabina,Lee Smith,Antonina V Starodubova,Aleksandar Stevanović,Prof Saverio Stranges,Yvonne Teuschl,Roman Topor-Madry,Mathilde Touvier,Marcos Roberto Tovani-Palone,Brigid Unim,Prof Tommi Juhani Vasankari,Victor Volovici,Hatem A Wafa,Yanzhong Wang,Ronny Westerman,Prof Charles D A Wolfe,Metin Yesiltepe,Aurora Zanghì,Prof Mikhail Sergeevich Zastrozhin
DOI: https://doi.org/10.1161/strokeaha.122.042022
IF: 10.17
2024-01-23
Stroke
Abstract:Stroke, Volume 55, Issue 2, Page 432-442, February 1, 2024. BACKGROUND:While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. The objective of this analysis was to evaluate the stroke burden across European regions and countries in 2019 and its difference to 2010.METHODS:The GBD 2019 analytical tools were used to evaluate regional and country-specific estimates of incidence, prevalence, deaths, and disability-adjusted life years of stroke for the European Region as defined by the World Health Organization, with its 53 member countries (EU-53) and for European Union as defined in 2019, with its 28 member countries (EU-28), between 2010 and 2019. Results were analyzed at a regional, subregional, and country level.RESULTS:In EU-53, the absolute number of incident and prevalent strokes increased by 2% (uncertainty interval [UI], 0%–4%), from 1 767 280 to 1 802 559 new cases, and by 4% (UI, 3%–5%) between 2010 and 2019, respectively. In EU-28, the absolute number of prevalent strokes and stroke-related deaths increased by 4% (UI, 2%–5%) and by 6% (UI, 1%–10%), respectively. All-stroke age-standardized mortality rates, however, decreased by 18% (UI, −22% to −14%), from 82 to 67 per 100 000 people in the EU-53, and by 15% (UI, −18% to −11%), from 49.3 to 42.0 per 100 000 people in EU-28. Despite most countries presenting reductions in age-adjusted incidence, prevalence, mortality, and disability-adjusted life year rates, these rates remained 1.4×, 1.2×, 1.6×, and 1.7× higher in EU-53 in comparison to the EU-28.CONCLUSIONS:EU-53 showed a 2% increase in incident strokes, while they remained stable in EU-28. Age-standardized rates were consistently lower for all-stroke burden parameters in EU-28 in comparison to EU-53, and huge discrepancies in incidence, prevalence, mortality, and disability-adjusted life-year rates were observed between individual countries.
peripheral vascular disease,clinical neurology